Clinical trial
Pulmicort Asthma Prevention (Post-PAC)
NCT00233584 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00233584 |
|---|---|
| Title | Pulmicort Asthma Prevention (Post-PAC) |
| Official title | A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC) |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Procedure |
| Interventions | Pulmicort (budesonide) pMDI |
| Enrollment | 400 |
| Start date | Jul 1, 2001 |
| Primary completion | May 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Oct 6, 2005 |
| Last update posted | Jan 14, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: